AbCellera Results Presentation Deck

STRONG 19 GROWTH OF CORE BUSINESS LAR BIOLOGIC CLAS Q2 2021. BUSINESS UPDATE SUMMARY. AbCellera NEW programs under contract 6 NEW programs started 3 MOLECULES entered clinical testing Abtellera Nikon 138 cumulative programs under contract $792.6M in cash & cash equivalents $65M in accounts receivable (AR) + accrued AR

View entire presentation